Pro Flora Colonizer

Listen to an audio summary of Pro Flora Colonizer

A proprietary blend of Lactobacillus acidophilus, Bifidobacterium and Lactobacillus rhamnosus. Utilizing the MAKTrek gastric bypass system for maximum bacterial protection and live delivery to intestinal target tissues.  Live probiotic support for healthy intestinal function.

• Supports the delicate balance of intestinal microflora for a healthy gut/vaginal ecosystem
• Supports a healthy immune system
• Protectant antioxidant properties
• Preliminary evidence for beneficial support in food sensitivity patients
• Improved digestion of lactose, maltose and sucrose

PRO FLORA COLONIZER is a potent, viable, combination of human strain Lactobacillus acidophilus (LA), Bifidobacterium(BB), and Lactobacillus rhamnosus (LR). These strains of beneficial intestinal bacteria have a favorable effect on the balance of microorganisms in the human intestine. A healthy balance of intestinal microflora is important for the maturation of the immune system and the structural integrity of the intestinal lining. Probiotics are able to enhance the barrier function of the intestinal mucosa, thus reducing the adherence of pathogens and the absorption of allergens. Probiotics may also reduce allergenic responses and conditions such as leaky gut via mediation of the inflammatory response of the intestinal lining. Probiotic bacteria are also responsible for the synthesis of certain essential nutrients, including vitamin K, B12, and biotin.

Serving size: 1 capsule
Number of servings per container: 60

Amounts per serving

• L. acidophilus 3 billion
• Bifidobacterium 3 billion
• L. rhamnosus 3 billion
• Total 9 billion

Other Ingredients: Malodextrin, complex polysaccharides, stearic acid, magnesium stearate, cellulose.

Suggested Dose: As a dietary supplement, take 1 capsule 1-2 times per day or as directed by your health care professional.

Keep tightly capped and store in a cool dry place.
Keep out of reach of children.

Read customer questions and answers about Digestive Health on our blog.

MAKTrek Bypass Technology. This state of the art system utilizes an innovative, polysaccharide complex which acts as a protective barrier to ensure intact delivery to the small intestine. Most probiotic capsules begin to break down upon entering the acidic environment of the stomach, thus exposing their contents to destructive gastric acids and enzymes. The MAKTrek technology provided in ProFlora Colonizer offers a new level of stability for increased survival rate of microorganisms through the GI tract. As the ProFlora Colonizer veggie capsule begins degradation by the stomach?s acids, water enters the capsule and binds to the MAKTrek polysaccharide mixture, forming an insoluble complex which acts as a secondary protective coating. This coating protects the probiotic bacteria from the harsh acidic environment of the stomach, resulting in a copious increase in intestinal implantation for optimal health supporting benefits.

Lactobacillus acidophilus (LA): inhabits the human intestine and vagina. To date 56 species of Lactobacillus have been identified. LA appears to enhance phagocytic activity of circulating granulocytes. LA may help prevent antibiotic ? related diarrhea. In human volunteers LA has exhibited the ability to inhibit bacteria that convert precarcinogens into carcinogens. Dairy products containing viable strains of LA have been credited with lowering cholesterol in animal experiments. It is theorized that this may be due to reduced enterohepatic circulation

Lactobacillus rhamnosus (LR): has shown several promising benefits for human health. Specifically, LR has been shown to eradicate Clostridium difficile in patients with relapsing colitis. LR has been shown to potentiate intestinal immune response to rotavirus infection in children. LR seems to have some anticancer effects in rats. When given a chemical to induce intestinal tumors the LR bacteria inhibited their development. LR appears to alter the initiation and promotion stages of chemically induced tumors. This may in part be due to LR?s ability to bind chemical carcinogens. By reinforcing the barrier function of the intestinal wall, LR colonization helps in the management of food allergies. Children with food allergy induced skin disorders had significant improvement with LR and BB strain of probiotics. These bacteria helped to balance the Th1/Th2 immune response in these patients. LR is better able to colonize the colon than certain other strains of LAB.

Bifidobacterium (BB): has been shown to eradicate Campylobacter jejuni from the stools of children with enteritis. BB also seems to enhance the phagocytic activity of granulocytes. Children with food allergy induced skin disorders had significant improvement with LR and BB strain of probiotics. These bacteria helped to balance the Th1/Th2 immune response in these patients.

References:

1. PDR for Nutritional Supplements, 1st Edition, 2001. Medical Economics, Thomson Healthcare. Montvale, New Jersey.
2. Arunachalam K, Gill HS, Chandra RK. Enhancement of natural immune function by dietary consumption of bifidobacterium lactis. Eur J Clin Nutr. 2000; 54:263-267.
3. Arunachalam KD. Role of bifidobacterium in nutrition, medicine and technology. Nutr Res. 1999; 19:1559-1597.
4. Blum S, Reniero R, Schiffrin EJ, et al. Adhesion studies for probiotics: need for validation and refinement. Trends Food Sci Technol. 1999; 10:405-410.
5. Dugas B, Mercenier A, Lenoir-Wijnkoop I, et al. Immunity and probiotics. Immunol Today. 1999; 20:387-390.
6. Gionchetti P, Rizzello F, Venturi A, Campieri M. Probiotics in infective diarrhoea and inflammatory bowel diseases. J Gastroenterol Hepatol. 2000.; 15:489-493.
7. Gomes AMP, Malcata FX. Bifidobacterium spp. And Lactobacillus acidophilus: biological, technological and therapeutical properties relevant to use as probiotics. Trends Food Sci Technol. 1999; 10:139-157.
8. Lin M-Y, Yen C-L. Antioxidant ability of lactic acid bacteria. J Agric Food Chem. 1999; 47:1460-1466.
9. Majamaa H, Isolauri E. Probiotics: a novel approach in the management of food allergy. J Allergy Clin Immunol. 1997; 99:179-185.
10. Metchnikoff E. The Prolongation of Life: Optimistic Studies. The English translation. Mitchell PC, ed. 1908: New York:GP Putnam?s Sons: 1908.
11. Saavedra J. Probiotics and infectious diarrhea. Am J Gastroenterol. 2000; 95(1 Suppl):S16-S18.
12. Symposium: Probiotic Bacteria: Implications for Human Health. J Nutr. 2000; 130:382S-409S.